Multicenter phase II trial to investigate safety and efficacy of an adjuvant therapy with gemcitabine and cetuximab in patients with R0 or R1 resected pancreatic cancer.

H Fensterer, Carmen Schade‐Brittinger, Hans‐Helge Mueller et al.|Journal of Clinical Oncology|2011

Cited by 2